CDC Releases Updated ACIP Immunization Recommendations for 2017

The CDC has released its final 2017 updated adult vaccination recommendations approved by the Advisory Committee on Immunization Practices (ACIP).

The CDC has released its final 2017 updated adult vaccination recommendations approved by the Advisory Committee on Immunization Practices (ACIP).

The guidelines include information on the use of influenza, human papillomavirus (HPV), hepatitis B (HBV), and meningococcal vaccines. Among the updated changes include modifications to flu vaccines for individuals with egg allergies and details on vaccinating at-risk populations.

These are some of the key changes in the final guidelines:

  • The recommendations on HBV vaccinations have been updated. The guidelines now recommend that adults with HCV infection, or other chronic liver conditions, and liver function enzyme levels twice the upper limit should be vaccinated. The presence of an immunocompromising condition is no longer a specific indication for HBV vaccination.

  • ACIP advises against use of LAIV during the 2016-2017 influenza season.

  • Adults with only hives as mild egg allergy symptoms should be given age-appropriate inactivated flu vaccine or recombinant vaccine. Individuals with severe symptoms should be vaccinated in a medical setting.

  • Adults who did not begin HPV vaccination before the age of 15 still require a 3-dose regimen, rather than the 2-dose series that was previously approved for children and adolescents. Women through the age of 26 and men through the age of 21 who have not received vaccinations should begin a 3-dose regimen, with a dosing schedule of 0, 1 to 2, and 6 months.

  • All adults who have HIV should receive routine 2-dose meningococcal vaccination that covers A, C, W, and Y serotypes, and are at least 2 months apart. Individuals should be revaccination every 5 years.

  • Healthy young adults who are not at an increased risk of serogroup B meningococcal disease can receive just 2 doses of MenB-FHbp vaccine at 0 and 6 months for short-term protection.

The revisions for the updated recommendations were voted on at ACIP’s October 2016 meeting. The full ACIP recommendations for each vaccine can be found here.

Reference

Kim DK, Riley LE, Harriman KH, et al. Recommended immunization schedule for adults aged 19 Years or Older, United States, 2017*. Ann Intern Med. 2017;166(3):209-219. doi: 10.7326/M16-2936.